Celldex Therapeutics, Inc Share Price
NASDAQ: CLDXHealthcare
Live Celldex Therapeutics, Inc Share Price Chart
O H L
Celldex Therapeutics, Inc Performance Overview
Days Range
▼
$37.79Low
$38.50High
Markets Today
| Previous Close | $38.98 |
|---|---|
| Open | $38.50 |
| Volume | 184,993 |
| Day's Range | $37.79 - $38.50 |
| 52W Range | $22.10 - $45.14 |
| Market Cap | $3.04 B |
Historical Performance
| 1M Returns | -6.72 |
|---|---|
| 3M Returns | +20.20 |
| 6M Returns | +36.58 |
| 1Y Returns | +50.39 |
| 5Y Returns | -28.33 |
| 10Y Returns | -29.19 |
Celldex Therapeutics, Inc Fundamentals
| Market Cap | $3.04 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.54 M |
| ROE TTM | -0.41 |
| EPS TTM | $-4.36 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.25 |
| EBITDA | $-283.99 M |
| Profit Margin | -16748.03 |
| Market Cap | $3.04 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.54 M |
| ROE TTM | -0.41 |
| EPS TTM | $-4.36 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.25 |
| EBITDA | $-283.99 M |
| Profit Margin | -16748.03 |
Celldex Therapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $695.00 K | $730.00 K | $0 | $121.00 K | $15.00 K | $22.00 K |
| Gross Profit + | $695.00 K | $730.00 K | $0 | $121.00 K | $15.00 K | $22.00 K |
| Operating Income | -$62.74 M | -$63.86 M | -$73.62 M | -$87.15 M | -$84.44 M | -$80.62 M |
| EBITDA | -$61.87 M | -$62.98 M | -$72.79 M | -$86.34 M | -$83.58 M | -$79.72 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $867.00 K | $873.00 K | $824.00 K | $816.00 K | $854.00 K | $902.00 K |
| Income Before Tax | -$53.80 M | -$56.60 M | -$67.04 M | -$81.32 M | -$78.69 M | -$73.50 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$53.80 M | -$56.60 M | -$67.04 M | -$81.32 M | -$78.69 M | -$73.50 M |
| Net Profit Margin | -7740.43% | -7753.42% | - | -67204.13% | -524566.67% | -334104.55% |
Celldex Therapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $66.00 K | $66.00 K | $66.00 K | $67.00 K | $67.00 K | $79.00 K |
| Reserve & Surplus | -$1.61 B | -$1.66 B | -$1.73 B | -$1.81 B | -$1.89 B | -$1.96 B |
| Non-Current Liabilities | $4.47 M | $4.04 M | $3.61 M | $4.83 M | $3.56 M | $6.46 M |
| Current Liabilities | $32.02 M | $32.96 M | $46.47 M | $50.99 M | $51.47 M | $61.33 M |
| Total Liabilities | $36.49 M | $37.00 M | $50.08 M | $55.82 M | $55.03 M | $67.78 M |
| Fixed Assets | $31.79 M | $31.58 M | $32.02 M | $32.52 M | $34.59 M | $36.95 M |
| Current Assets | $693.76 M | $648.40 M | $604.34 M | $534.66 M | $459.22 M | $724.93 M |
| Total Assets | $739.47 M | $692.41 M | $648.44 M | $582.98 M | $511.25 M | $782.35 M |
Celldex Therapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$53.80 M | -$56.60 M | -$67.04 M | -$81.32 M | -$78.69 M | -$73.50 M |
| Operating Cash Flow | -$54.37 M | -$44.01 M | -$48.63 M | -$63.94 M | -$65.59 M | -$57.41 M |
| Investing Cash Flow | $42.95 M | $49.85 M | $60.85 M | $55.42 M | $72.12 M | -$255.52 M |
| Financing Cash Flow | $202.00 K | $63.00 K | $774.00 K | $1.35 M | $327.00 K | $324.66 M |
| Change in Cash | -$11.22 M | $5.91 M | $12.99 M | -$7.17 M | $6.86 M | $11.72 M |
Celldex Therapeutics, Inc Return Calculator
The Celldex Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$6,926
Invested Amount$10,000
Est. Returns$-3,074
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Popular Stocks
FAQs
What is the share price of Celldex Therapeutics, Inc today?
Celldex Therapeutics, Inc (CLDX) share price as of September 18, 2026 is $37.67. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Celldex Therapeutics, Inc?
Yes, Indian Investors can invest in the Celldex Therapeutics, Inc (CLDX) Share by opening an international trading account with Angel One.
How can I purchase Celldex Therapeutics, Inc shares in India?
Purchasing Celldex Therapeutics, Inc (CLDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Celldex Therapeutics, Inc (CLDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Celldex Therapeutics, Inc?
Yes, you can purchase fractional shares of Celldex Therapeutics, Inc (CLDX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Celldex Therapeutics, Inc?
The market capitalization of Celldex Therapeutics, Inc on September 18, 2026, is $3.04 B.
In which sector Celldex Therapeutics, Inc belongs?
Celldex Therapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Celldex Therapeutics, Inc stocks?
In order to invest in Celldex Therapeutics, Inc (CLDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
